Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist-Reference-Cited by-同舟云学术

Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist

Published:1987-02 Issue:1-2 Volume:20 Page:40-49
ISSN:0065-4299
Container-title:Agents and Actions
language:en
Short-container-title:Agents and Actions

Author:

Fleisch J. H.,Rinkema L. E.,Haisch K. D.,Whitesitt C. A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Toxicology,Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/BF01965624.pdf

Reference20 articles.

1. D. S. Pearlman,Antihistamines: Pharmacology and clinical use. Drugs12, 258–273 (1976).

2. W. W. Douglas,Histamine and 5-hydroxytryptamine (serotonin) and their antagonists InThe Pharmacological Basis of Therapeutics, 6th Edition (Eds. A. G. Gilman, L. S. Goodman and A. Gilman). MacMillan, New York 1980, pp. 609–646.

3. K. F. Austen,A review of immunological, biochemical and pharmacological factors in the release of chemical mediators from human lung. InAsthma: Physiology, Immunopharmacology, and Treatment (Eds. K. F. Austen and L. M. Lichtenstein). Academic, New York, 1973, pp. 109–122.

4. N. M. Eiser,Histamine antagonists and asthma. Pharmac. Ther.17, 239–250 (1982).

5. T. Fukuda, Y. Morimoto, R. Iemura, T. Kawashima, G. Tsukamoto and K. Ito,Effect of 1-(2-Ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate (KB-2413), a new antiallergic, on chemical mediators. Arzneim.-Forsch./Drug Res.34(II), 801–805 (1984).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic antiallergic activity of combined histamine H1- and cysteinyl leukotriene1-receptor blockade in human bronchus;Life Sciences;2001-05

2. Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment;European Journal of Clinical Pharmacology;2001-02-22

3. Drug therapy for ocular allergy;Expert Opinion on Investigational Drugs;1998-01

4. Inhibition of Human Eosinophil Chemotaxis in Vitro by the Anti-Allergic Agent Emedastine Difumarate;Immunopharmacology and Immunotoxicology;1996-01

5. Histamine receptor-subtype affinities, selectivities, and potencies of emedastine, a novel H1-selective antagonist, and other ocularly employed antihistamines;Drug Development Research;1994-12